Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 6/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 6/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 7/20 | 0.83 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.83 |
| ▸ | TP53 | P04637 | 3/20 | 0.83 |
| ▸ | CA12 | O43570 | 3/20 | 0.83 |
| ▸ | CA4 | P22748 | 3/20 | 0.83 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.83 |
| ▸ | CA7 | P43166 | 3/20 | 0.83 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.83 |
| ▸ | MAPT | P10636 | 3/20 | 0.83 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.83 |
| ▸ | XDH | P47989 | 2/20 | 0.83 |
| ▸ | HPGD | P15428 | 2/20 | 0.83 |
| ▸ | PKM | P14618 | 2/20 | 0.83 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.83 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.83 |
| ▸ | DPP4 | P27487 | 2/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Homoeriodictyol SCHEMBL30383489 | 1.00 | CYP1A1 (1.00) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| Homoeriodictyol SCHEMBL39497 | 1.00 | CYP1A1 (1.00) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| Homoeriodictyol SCHEMBL30016824 | 1.00 | CYP1A1 (1.00) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| Homoeriodictyol SCHEMBL29411740 | 1.00 | CYP1A1 (1.00) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| Homoeriodictyol SCHEMBL1505910 | 0.99 | CYP1A1 (0.98) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| Homoeriodictyol SCHEMBL2024548 | 0.99 | CYP1A1 (0.98) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| Homoeriodictyol SCHEMBL2019518 | 0.99 | CYP1A1 (0.98) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| Homoeriodictyol SCHEMBL7535609 | 0.99 | CYP1A1 (0.98) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| Homoeriodictyol SCHEMBL3422048 | 0.98 | CYP1A1 (0.95) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 | |
| SCHEMBL31028356 | 0.93 | CYP19A1 (0.87) | CYP1A1CYP1A2CYP1B1POLBCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021042001-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | Natural Extraction Systems, LLC (US) | 2021-03-04 | — | — | WO | claimed |
| EP-1258200-B1 | Use of hydroxyflavones for masking of bitterness, and food and pharmaceutical compositions comprising an effective amount thereof | SYMRISE GMBH & CO KG (DE) | 2005-02-16 | — | — | EP | claimed |
| US-20020188019-A1 | Use of hydroxyflavanones for masking bitter taste | SYMRISE AG (DE) | 2002-12-12 | — | — | US | claimed |
| EP-1258200-A2 | Use of hydroxyflavones for masking of bitterness, and food and pharmaceutical compositions comprising an effective amount thereof | HAARMANN & REIMER GMBH (DE) | 2002-11-20 | — | — | EP | claimed |
| EP-4699452-A2 | OBTAINING A VOLATILE FRACTION FROM JUICES OR ALCOHOLIC BEVERAGES | Symrise AG (DE) | 2026-02-25 | — | — | EP | disclosed |
| US-20260041109-A1 | ROBUST FLAVOR EMULSIONS | INT FLAVORS & FRAGRANCES INC (US) | 2026-02-12 | — | — | US | disclosed |
| EP-3836799-B1 | OBTAINING A VOLATILE FRACTION FROM JUICES OR ALCOHOLIC BEVERAGES | SYMRISE AG (DE) | 2025-11-26 | — | — | EP | disclosed |
| US-12419815-B2 | Microcapsule compositions stabilized with viscosity control agents | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-09-23 | — | — | US | disclosed |
| US-12357547-B2 | Compositions containing microcapsules | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-07-15 | — | — | US | disclosed |
| US-12324452-B2 | Delivery systems and methods of preparing the same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-06-10 | — | — | US | disclosed |
| US-12274771-B2 | Polyurea capsule compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-04-15 | — | — | US | disclosed |
| US-12030326-B2 | System and method for printing and drying flavors and fragrances | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2024-07-09 | — | — | US | disclosed |
| US-7268115-B2 | Cyclic peptides; three-dimensional structures; screening; anticancer agents; angiogenesis inhibitors; drug delivery | ADHEREX TECHNOLOGIES, INC. (CA) | 2007-09-11 | — | — | US | disclosed |
| EP-1258200-B1 | Use of hydroxyflavones for masking of bitterness, and food and pharmaceutical compositions comprising an effective amount thereof | SYMRISE GMBH & CO KG (DE) | 2005-02-16 | — | — | EP | disclosed |
| WO-2004041804-B1 | TECHNICAL PROCESS FOR ISOLATING HOMOERIODICTYOL | SYMRISE GMBH & CO KG (DE) | 2005-01-27 | — | — | WO | disclosed |
| WO-2004041804-A3 | TECHNICAL PROCESS FOR ISOLATING HOMOERIODICTYOL | SYMRISE GMBH & CO KG (DE) | 2004-12-09 | — | — | WO | disclosed |
| WO-2004041804-A2 | TECHNICAL PROCESS FOR ISOLATING HOMOERIODICTYOL | SYMRISE GMBH & CO. KG (DE) | 2004-05-21 | — | — | WO | disclosed |
| WO-2004041804-A2 | TECHNICAL PROCESS FOR ISOLATING HOMOERIODICTYOL | SYMRISE GMBH & CO. KG (DE) | 2004-05-21 | — | — | WO | disclosed |
| US-20020188019-A1 | Use of hydroxyflavanones for masking bitter taste | SYMRISE AG (DE) | 2002-12-12 | — | — | US | disclosed |
| EP-1258200-A2 | Use of hydroxyflavones for masking of bitterness, and food and pharmaceutical compositions comprising an effective amount thereof | HAARMANN & REIMER GMBH (DE) | 2002-11-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12357547-B2 | Compositions containing microcapsules | COPE, SAAL1, AUP1 | CYP1A1 4650/4885CYP1A2 4690/4885CYP1B1 4578/4885 |
| US-12324452-B2 | Delivery systems and methods of preparing the same | MAL2, TAS2R42, TAS2R31 | CYP1A1 374/4885CYP1A2 414/4885CYP1B1 583/4885 |
| US-12419815-B2 | Microcapsule compositions stabilized with viscosity control agents | ACR, ALG1, MLEC | CYP1A1 4831/4885CYP1A2 4836/4885CYP1B1 4744/4885 |
| US-20020188019-A1 | Use of hydroxyflavanones for masking bitter taste | TAS2R60, TAS2R50, TAS2R30 | CYP1A1 1504/4885CYP1A2 630/4885CYP1B1 1772/4885 |
| US-12274771-B2 | Polyurea capsule compositions | PUF60, UMPS, PCBP1 | CYP1A1 4767/4885CYP1A2 4802/4885CYP1B1 4641/4885 |
| US-20260041109-A1 | ROBUST FLAVOR EMULSIONS | ACACA, FABP4, CUTA | CYP1A1 2995/4885CYP1A2 2577/4885CYP1B1 2649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.